Prognostic Stratification of Multiple Myeloma Using Clinicogenomic Models: Validation and Performance Analysis of the IAC-50 Model

A growing need to evaluate risk-adapted treatments in multiple myeloma (MM) exists. Several clinical and molecular scores have been developed in the last decades, which individually explain some of the variability in the heterogeneous clinical behavior of this neoplasm. Recently, we presented Iacobu...

Descripción completa

Detalles Bibliográficos
Autores principales: Mosquera Orgueira, Adrián, González Pérez, Marta Sonia, Díaz Arias, José Ángel, Antelo Rodríguez, Beatriz, Mateos, María-Victoria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348861/
https://www.ncbi.nlm.nih.gov/pubmed/35935610
http://dx.doi.org/10.1097/HS9.0000000000000760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348861/
https://www.ncbi.nlm.nih.gov/pubmed/35935610
http://dx.doi.org/10.1097/HS9.0000000000000760

Ejemplares similares